Replacement therapy of secondary hypothyroidism in children born with low body weight improves mental development

Area of Science:

• Pediatric endocrinology
• Neurodevelopmental pediatrics

Background:

• Secondary hypothyroidism is a known complication in children with brain damage.
• Preterm infants are particularly vulnerable to the effects of thyroid hormone deficiency on development.

Purpose of the Study:

• To evaluate the impact of early l-thyroxin replacement therapy on the mental development of preterm infants with secondary hypothyroidism.
• To compare developmental outcomes between preterm infants treated with l-thyroxin starting in the second week versus later weeks of life.

Main Methods:

• A comparative study of preterm newborns diagnosed with secondary hypothyroidism.
• Treatment groups received l-thyroxin at different starting points: second week of life versus fourth week or later.
• Motor development milestones were tracked, and cognitive function was assessed using the Wechsler Intelligence Scale for Children at seven years of age.

Main Results:

• Infants receiving early l-thyroxin treatment (from the second week) achieved motor milestones (sitting, standing, walking) significantly earlier.
• Cognitive assessments at seven years showed significantly higher IQ scores in the early treatment group compared to the delayed treatment group.
• Early, modest-dose l-thyroxin therapy demonstrated a clear benefit in motor development and long-term cognitive outcomes.

Conclusions:

• Initiating l-thyroxin replacement therapy in the second week of life can positively influence long-term mental development in preterm infants with secondary hypothyroidism.
• Early intervention in thyroid hormone deficiency is crucial for optimizing neurodevelopmental trajectories in vulnerable infant populations.
• The findings support the importance of timely diagnosis and treatment of secondary hypothyroidism in preterm infants to improve cognitive outcomes.